Travis Cordie, M.S. joined the team in 2016, bringing with his knowledge of bio manufacturing, genetic engineering, pluripotent stem cells and tissue engineering. Graduating from UW-Madison with a M.S. in Biomedical Engineering, studied reprogramming human pluripotent stem cells and tissue engineering. Post graduate school Travis worked at a Biomanufacturing facility gaining valuable cGMP experience and developing cellular therapies for phase 1 and 2 clinical trials.
Dr. Leah Hogdal, Ph.D. is a senior scientist at B-MoGen Biotechnologies and has extensive experience in mitochondrial, genetic, and cellular biology. She graduated summa cum laude from Gustavus Adolphus College with a degree in Honors Biology, received her PhD in Biological Chemistry and Molecular Pharmacology from Harvard University, and was a post-doctoral fellow at Vanderbilt University. Her doctoral and post-doctoral research focused on developing methods to predict mitochondrial apoptotic responses to cancer therapeutics in primary human cells.